Total number of patients | 101 |
---|---|
Sex distribution | 55.4% (56/101) male |
Median age [IQR] | 34 [10–41] years |
Median CD4 [IQR] | 129 [29–466] cells/μl |
Median viral load [IQR] | 71,630 [19,041-368,000] copies/ml |
ART regimens received by each group of patients, in addition to 3TC plus EFV or NVP | |
Group-A (n = 55) | both AZT and D4T |
Group-B (n = 22) | TDF + “D4T or AZT” |
Group-C (n = 24) | D4T (i.e. Triomune) |